Transaction · 0001193125-26-355502

Patel Sanjiv

Patel Sanjiv, PRES, reported an open-market or private sale at Relay Therapeutics, Inc. involving 48199.000000 shares for an estimated $979885.67. Reported holdings after the transaction were 567699.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
RLAYRelay Therapeutics, Inc.
Trade date
Aug 17, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value-$979kShares × reported price
Shares traded48.1k$20.33 per share
Holdings after567kDirect
% of reported position traded7.83%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 615,898 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RLAY price since this filing

Daily closing prices, with the filing date and available return windows
RLAY · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -3.4%1w ago -3.3%1d ago -3.6%
Returns since7d -0.7%30d -6.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-355502
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 08:17 PM · 1d delay
Shares
48,199 sh
$20.33 per share
Estimated value
-$979k
Computed from shares × price
Holdings after
567,699 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $19.56 to $20.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to p…

  3. F3

    These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownersh…

Original filing · 0001193125-26-355502
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RLAY